ArticleBMJ open2023

Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer (NECI Study): a protocol for a phase II study.

Yiqun Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.